Scopus Atıf Havuzu

Association between Low-Dose Rivaroxaban with or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial

Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system

Grey zones on the use of new oral anticoagulants in atrial fibrillation. Expert opinion

Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation

Patent foramen ovale, the role of antiplatelet therapy alone or antico-agulant therapy alone versus device closure for cryptogenic stroke: A review of the literature and current recommendations

Differential drug target selection in blood coagulation: What can we get from computational systems biology models?

Pressure-dependent nonlinear optical properties in a group III–V/II–VI core/shell quantum dot

Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice

The left atrial appendage morphology is associated with embolic stroke subtypes using a simple classification system: A proof of concept study

Dabigatran vs. aspirin for secondary prevention after embolic stroke of undetermined source - Japanese subanalysis of the RE-SPECT ESUS randomized controlled trial-

Impaired Endothelial Function in Embolic Stroke of Undetermined Source

Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment - Reply

Direct Anticoagulants and Risk of Myocardial Infarction, a Multiple Treatment Network Meta-Analysis

Heart and Embolic Stroke of Undetermined Source

Non-vitamin k oral anticoagulants (Noacs) in patients with stroke and atrial fibrillation

Off-label medicines use: Complex problem of modern clinical practice

Atrial cardiopathy in the absence of atrial fibrillation increases risk of ischemic stroke, incident atrial fibrillation, and mortality and improves stroke risk prediction

The paradoxical embolism phenomenon in patients with embolic cryptogenic stroke

Progressive ischaemic stroke: The difficulty in choosing antithrombotic therapy

Detection of atrial fibrillation using an implantable loop recorder following cryptogenic stroke: implications for post-stroke electrocardiographic monitoring